Financials
Financial year 2025
KCI MEDICAL BELGIUM from Peer, company number BE0476532096, closed financial year 2025 with a result of € 16.6 million after tax. For that financial year KCI MEDICAL BELGIUM recorded revenue of € 79.1 million and equity of € 28.3 million. Compared with financial year 2024, the result moved from € 3.5 million to € 16.6 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 14, 2026.
€ 28.3 million
▲ 141% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 16.6 million
▲ € 13 million vs 2024
Profit after tax over the fiscal year.
€ 0
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 21.6 million.
People and assets in 2025
78
▲ 2.4 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 13.6 million
▲ 16% vs 2024
€ 173,900 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 18.4 million
▼ 25% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 107 days on average.
€ 4.3 million
▲ 52% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | - | - | € 84,875,268 | € 79,097,677 | ▼ 7% |
| Gross margin | € -8,471 | € 2,418,850 | - | - | |
| Profit after taxes | € -7,469 | € 824,883 | € 3,529,595 | € 16,566,844 | ▲ € 13 million |
| Equity | € 6,080,209 | € 8,242,201 | € 11,771,796 | € 28,338,640 | ▲ 141% |
| Total debts | € 7,988 | € 18,435,252 | € 33,956,214 | € 31,649,145 | ▼ 7% |
| Cash | € 21,714 | € 51,682 | € 0 | € 0 | |
| Retained profit | € 718,891 | € 1,543,774 | € 5,073,370 | € 21,640,214 | ▲ € 16.6 million |
| Bank debt | € 0 | € 124,257 | € 0 | € 0 | |
| Balance sheet total | € 6,088,197 | € 26,807,121 | € 45,728,010 | € 59,987,785 | ▲ 31% |
| Employees (FTE) | - | 11.4 | 75.6 | 78 | ▲ 2.4 |
Key figures of KCI MEDICAL BELGIUM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to KCI MEDICAL BELGIUM?
What happened at KCI MEDICAL BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 16.6 million (▲ € 13 million vs 2024). Source: NBB ↗
- Jean-Luc Vanderlinden became a director. NBB
- Debby Polet stepped down as director. NBB
- Gerlinde De Meulenaer became a director. NBB
- Haluk Yilmaz stepped down as director. NBB
- Cagatay Guler became a director. NBB
- Haluk Yilmaz became a director. NBB
- Debby Polet became a director. NBB
In short
From € 7,469 loss in 2022 to € 16.6 million profit in 2025.
Paid € 7.2 million in corporate taxes since 2022.
Best year ever: 2025, with € 16.6 million profit.
On average € 212,200 of value added per employee in 2023.
A new publication or filing at KCI MEDICAL BELGIUM? We notify you, reason included.
Follow KCI MEDICAL BELGIUMDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind KCI MEDICAL BELGIUM are Gerlinde De Meulenaer, Jean-Luc Vanderlinden and Cagatay Guler. The shares are held by Solventum International Holdings Ltd. (100%). It owns 100% of KCI Polymedics itself.
Directors
According to the 2025 annual accounts
since 2025
Jean-Luc Vanderlinden
Director
since 2025
Cagatay Guler
Director
since 2024
Haluk Yilmaz
Director
since 2024 · until 2025
Debby Polet
Director
since 2024 · until 2025
Shareholders
Solventum International Holdings Ltd.
100%
Participations
100%
Establishments
Establishment units
Physical locations of this company
Ambachtslaan 1031
3990 Peer
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Certifications & Partners
Hosting & Email
Hosting
AMAZON-02 - Amazon.com, Inc., US
DNS
AWS Route 53
Website info
Features
Security
Network
Details
- Company number
- 0476.532.096
- VAT number
- BE 0476.532.096
- Registered office
- Ambachtslaan 1031, 3990 Peer
- Names & denominations
- KCI MEDICAL BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 31 December 2001
- Peppol
- Active · Active since 3 Aug 2026
- Contact
- kci-medical.be
- Activities · NACE
Groothandel in farmaceutische en medische artikelen